Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1673171 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Somatostatin Receptor 2 (SSTR2) (Middle Region) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence in the middle region of human SSTR2, identical to the related rat and mouse sequences.Immunogen affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- Middle Region
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references SOM230 combined with celecoxib prolongs the survival in nude mice with HepG-2 xenografts.
Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Xie Y, Chen S, Wang CH, Tang CW
Cancer biology & therapy 2011 Jul 1;12(1):86-92
Cancer biology & therapy 2011 Jul 1;12(1):86-92
Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
Hua YP, Yin XY, Peng BG, Li SQ, Lai JM, Liang HZ, Liang LJ
Chemotherapy 2009;55(5):312-20
Chemotherapy 2009;55(5):312-20
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.
Filopanti M, Ronchi C, Ballarè E, Bondioni S, Lania AG, Losa M, Gelmini S, Peri A, Orlando C, Beck-Peccoz P, Spada A
The Journal of clinical endocrinology and metabolism 2005 Aug;90(8):4824-8
The Journal of clinical endocrinology and metabolism 2005 Aug;90(8):4824-8
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.
Guillermet J, Saint-Laurent N, Rochaix P, Cuvillier O, Levade T, Schally AV, Pradayrol L, Buscail L, Susini C, Bousquet C
Proceedings of the National Academy of Sciences of the United States of America 2003 Jan 7;100(1):155-60
Proceedings of the National Academy of Sciences of the United States of America 2003 Jan 7;100(1):155-60
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, Kalthoff H, Lluis F, Vaysse N, Susini C
Cancer research 1996 Apr 15;56(8):1823-7
Cancer research 1996 Apr 15;56(8):1823-7
No comments: Submit comment
No validations: Submit validation data